Introduction
Introduction

Cardiovascular disease is a leading cause of morbidity and mortality worldwide. Heart-related injuries, such as myocardial infarction (MI), lead to an irreversible loss of cardiac cells followed by ventricular remodelling and finally by organ failure, in spite of aggressive pharmacotherapy and surgical procedures. Indeed, the limited mitotic capacity of cardiomyocytes cannot support myocardial self-renewal. To restore the function of a damaged heart, cell based therapies have been developed to supply the failing myocardial tissue with non-terminally differentiated cells capable of forming viable cardiomyocytes.
Among multiple candidate cell types isolated from cardiac or non-cardiac sources and possessing varying cardiogenic potential [1] [2] [3] , embryonic stem cells (ESC) derived from the inner cell mass of the blastocyst rank highest with regard to their cardiogenic potential (reviewed in [4] [6, 7] . Tissue microenvironment is thought to play a major role in cell differentiation towards specific phenotypes through the local release of growth factors and/or cytokines. For instance, differentiating mouse embryoid bodies (EBs) injected under the mouse skin or the renal capsule induced teratomas containing different cell types depending on the site of injection [8] . Engrafted into the spinal cord or brain of mice or rats, mESC differentiated towards neuronal cell types [9, 10] , while under the kidney capsule they transformed into other cell types coexisting into a heterogeneous tissue [11] . Within the knee joint of severe-combined immunodeficiency (SCID) mESC formed tumours [12] , whereas they differentiated into chondrocytes when injected into the rat joint [13] . Therefore, differences in the microenvironment into which cells are embedded are likely to influence the differentiation pathway. [14, 15] 
Two recent papers reported that undifferentiated mESC injected in a rat model of MI, fully differentiated towards functional cardiomyocytes in situ without the need for immunosuppression and led to an improvement of heart function
Materials and methods
Embryonic stem cell preparation for transplantation
We genetically modified the mouse ESC line CGR8 [16] [20] . [22] . [23] . All measurements were averaged for three consecutive cardiac cycles. The data were expressed as delta of parameters (see Table 1 ). 
Evaluation of left ventricular function by echocardiography
Left ventricular function was assessed by transthoracic echocardiography before cell engraftment (in normal, acute or chronic MI) and before sacrifice, i.e. 1 or 4 weeks after transplantation. Rats were anaesthetized by isofluorane (first 4-5% than 1-2%), continuously supplied via a mask
All two-dimensional images, M-mode tracings and Doppler curves were recorded on videotape for later analysis. We calculated the fractional shortening (FS) as a measure of systolic function, according to the M-mode tracings obtained from the short-axis parasternal view: maximal LV end-diastolic diameter (LVEDD, measured at the time of the QRS deflection), minimal LV end-systolic diameter (LVESD, measured at the time of end-systole), FS (%) = [(LVEDD -LVESD)/LVEDD] ϫ 100
Histological and immunohistochemical study
Statistics analysis
All values are presented as means Ϯ S.E. Difference between two groups was compared by unpaired Mann-Whitney U-test. A level of P < 0.05 was considered as significant.
Results
Xenotransplantation of undifferentiated mouse ESC into the normal rat heart
To assess the potential of the rat heart to induce undifferentiated xenogenic mESC to differentiate into cardiomyocytes in situ, we studied the engraftment of four different mESC lines: wild-type feeder cell-independent CGR8, stable CGR8 clones expressing the eGFP-CD63 fusion protein (Fig. 1A and B) or the human Bcl2 protein (hBcl2, Fig. 1C and D (Fig. 1E) . Moreover, mESC displayed higher resistance to apoptosis upon exposure to reactive oxygen species (Fig. 1F) . Of note, our mESC revealed a positive staining for MHC class 1, but not class II (Fig.  1G and H) .
We first tested whether mESC could engraft and survive in a healthy rat myocardium in the absence of immune suppression. We histologically examined hearts either 1 or 4 weeks after transplantation of undifferentiated eGFP-CD63 or hBcl2-positive mESC (Fig. 2, n = 5 and n = 8, respectively) . Healthy heart sections stained with haematoxylin and eosin revealed the presence of granulation tissue ( Fig. 2A and B Fig. 2C and D) . At both time-points, no marker-positive mESC were identified at the site of injection, as illustrated by the absence of hBcl2 (0/13, Fig. 2D (Fig. 2E and F) , later histologically confirmed as small teratomas at the injection site. At 4 weeks, all animals (n = 6) presented large teratomas located within the left ventricular wall and often exceeding the left ventricular wall thickness ( Fig. 2G and H) . These tumours were highly proliferative (strong PCNA staining, see Fig. 5G and H) , and revealed heterogeneous staining for hBcl2 (Fig. 2F and H) By macroscopic and histological examination we identified teratomas as tumours disrupting the muscle cytoarchitecture (Fig. 3A) and containing tissue originating from the endoderm (epithelium of pancreas and bronchi, Fig. 3B and C) , the mesoderm (muscle and cartilage, Fig. 3D and E) and the ectoderm (skin, Fig. 3F) (Fig. 4A, B Fig. 4E and F) . This was also the case in normal ESC-injected hearts (Fig. 2C and D) .
) 1 week after engraftment (also containing MHC-II-positive cells, not shown), whereas this was no longer observed 4 weeks after implantation (
and G), acutely infarcted ventricular walls showed granulation tissue at 1 week post-MI, detected by haematoxylin and eosin or using proliferation and cardiac markers (MHC) (Fig. 4C, D and H). Instead, granulation tissue with MHCpositive infiltrating cells (data not shown) was not observed at 4 weeks post-MI, both in sham-injected (n = 8, not shown) or ESC-injected hearts (
In parallel, we tested cell survival and fate in immunosupressed animals. Figure 5A- (Fig. 5G and H) , and for eGFP (Fig. 5F ), or hBcl2 ( Fig. 2F and H) . In acutely infarcted CsA + rats (1 week MI) examined Fig. 4E ). The tumours were positive for either eGFP ( Fig. 6A and B) or hBcl2 (Fig. 6F) , as well as PCNA-positive (Fig. 6G) .
week after injection, we found teratomas in 3 out of 5 hearts (60%),
Table 1 Left ventricular function in post-infarcted rat models Effect of CsA treatment in acute myocardial infarction (MI = 1 week), 4 weeks after transplantation, and comparison between acute and chronic myocardial infarction, i.e. MI = 1 week versus MI = 4 weeks in the presence of CsA.
Parameters are expressed as difference (⌬) between values measured in infarcted hearts after and before transplantation (T), in the presence of CsA. Effect was evaluated 4 weeks after cell transplantation. LVEDD, left ventricular end diastolic diameter; LVESD, left ventricular end systolic diameter; FS, fractional shortening. The formula is expressed as follows: (LVEDD after T -LVEDD before T) and (LVESD after T -LVESD before T), values are mean ± standard error (SE
weeks presented highly proliferating teratomas (n = 13). Histological evaluation confirmed the presence of transmural scar tissue in a large portion of the left ventricular wall (n = 21), accompanied by a dilatation of the left ventricle (see also
In summary, 4 weeks after implantation, undifferentiated mESC formed teratomas in either normal, acutely or chronically infarcted rat hearts only when the animals were immunosupressed.
Importantly, we preferentially detected eGFP-positive cardiomyocytes displaying aligned sarcomeres (Fig. 6C and D) within the tumoural mass of infarcted animals but also at the peripheral (Fig. 6D) (Fig. 6B, D, F and H) .
Fig. 2 Fate of undifferentiated mouse ESC transplanted into a normal rat heart as a function of time and immune suppression treatment. (A-C) Haematoxylin and eosin (H & E) staining and (D) hBcl2 immunohistochemistry of heart sections 1 week and 4 weeks after cell transplantation in the absence of CsA. Magnification: A, C, D = ϫ10; B = ϫ50. (E, G) Haematoxylin and eosin staining and (F, H) hBcl2 immunohistochemistry of heart sections at 1 and 4 weeks after engraft-
Effect of time and immunosuppression on teratoma formation
As summarized in Figure 7, 
Evaluation of cardiac function in xenotransplanted animals
Fig. 4 Histomorphology and immunohistochemical evaluation of rat heart sections. (A, B) Haematoxylin and eosin staining of normal rats, (C, D) acutely infarcted heart (1 week MI) and (E, F) chronically infarcted hearts (4 weeks MI). Magnification: A, C, E = ϫ10, B, D, F = ϫ400. (G, H) Immunohistochemical staining of different markers present in heart sections of normal (G) and acutely infarcted rats (1 week MI, H). Top insets illustrate macroscopic views of the explanted heart. The white triangles indicate the coronary ligature suture (either shame or true), while the dotted oval shows the infarction area (hypointense whitish zone).
Granulation tissue and disruption of myocardial architecture is visible in 1-week MI hearts. 
Fig. 5 Fate of undifferentiated eGFP-ESC 4 weeks after their transplantation (T) into acutely infarcted hearts (1 week MI), in the absence (A-D) or presence (E-H) of CsA treatment. Haematoxylin and eosin and immunohistochemistry staining with: PCNA (C and G, H) and eGFP (D and F). In the absence of CsA, a fibrotic tissue devoid of transplanted mESC is visible (A-D). Magnification: A, E, G = ϫ10, C-D and F, H = ϫ50. L = coronary ligation; I = cell injection.
Fig. 6 Identification of ESC-derived cardiomyocytes into the teratoma masses in (A-D) 1 week or (E-H) 4 weeks MI hearts, both analysed 4 weeks after cell engraftment in the presence of CsA. EGFP-labelled ESC are shown for 1 week MI (A, B) while hBcl2-transduced ESC are illustrated for 4 weeks MI (F). Differentiating ESC positive for myosin heavy chains (MHC) were identified in both conditions (C, D and H). Tumours contained proliferating PCNA-positive cells (G)
.
Discussion
We [29] [30] [31] [32] . Second, undifferentiated and differentiated ESC appeared resistant to killing by activated NK cells [30] , as they lack costimulatory molecules and Nk lysis receptors [33, 34] (data not confirmed by [35] ). Potential mechanisms include: (i) contact-independent inhibition of CD4+ T-cell proliferation [34] via a TGF␤-mediated inhibition of dendritic cells [34, 36] , (ii) local immunosuppressive cell-cell paracrine factors, i.e. Serpin-6 (serine protease inhibitor 6)-mediated resistance of mESC and EBs to CTL-mediated lysis [34, 36] [29, 35] . Third, intraportal injection of undifferentiated rat ES cell-like cells into fully MHC-mismatched rats induced a state of tolerance, allowing the subsequent long-term acceptance of second-set transplanted cardiac allografts [29] . However, this was not confirmed upon in utero transplantation of mouse foetuses with MHC-mismatched ESC [37] . Forth, xenogenic undifferentiated mESC survived and differentiated into cardiac cells within immunocompetent rat or sheep hearts [14, 15, 38] . In contrast, this was not the case in immunocompromized or allogeneic mice in which intense immune responses with infiltration of T and B cells led to graft removal [39] [40] [41] .
and (iii) tolerance induction via Fas ligand activation of CD95 and inducted apoptosis in recipient T cells (lack of ESC engraftment in Fas-deficient mice)
Whether chimerism does happen in a mouse-to-rat transplantation model, and whether injected mESC escape from the heart into the circulation, remains to be demonstrated. As our mESC were positive in vitro for MHC type 1 (but not for type II), we thus speculate that ESC are likely to be removed through the activation of the rat immune system, as in the case of allogenic setting [41] . Accordingly, as reported in a very recent publication by Robertson et al. [42] [47] . Moreover, calcineurin signalling does not appear to be required for the initial events of heart formation since mouse embryos with targeted mutations of calcineurin subunits undergo normal heart tube formation and cardiomyocyte differentiation [48, 49] . In line with our data, Nussbaum et al. also showed that undifferentiated mESC consistently formed teratomas in infarcted hearts of nude or immunocompetent syngeneic mice, while they were rejected if allogeneic via an up-regulation of class I and II MHC [41] , possibly mediated by IFN␥, as observed in vitro [30] .
Although puzzling, at this point we cannot exclude that in very specific xenogenic conditions, i.e. mouse to rat or mouse to sheep (as reported [14, 38] ), and provided a BMP2-mediated pre-commitment of ESC in vitro [14, 38, 50] the heart may constitute a permissive and cardiac instructive niche especially in fibrotic areas known to secrete TGF␤ [51] [52] [53] . A similar nicheinduced tumour-free neuronal differentiation was observed when mESC were engrafted into rat, but not mouse brain [54] . However, our xenotransplantation experiments designed to closely reproduced conditions used by Befhar et al. could not confirm these observations. Of note, two recent papers by Puceat and collaborators reported the inability to reproduce xenogenic transplantation of mouse ESC into baboon [55] , and achieved BMP2-treated hESC engraftment into rat hearts exclusively under immunosuppressive conditions [56] , suggesting that the xenogenic mouse to baboon and human to rat transplantation is not permissive. Consistent with this is the work by Grinnemo et al. [57] 
